Ultragenyx Pharmaceutical (RARE) Payables (2013 - 2026)
Ultragenyx Pharmaceutical (RARE) reported Payables of $39 million for Q2 2026, up 13.9% from $34.24 million a year earlier but down 7.1% from the prior quarter.
Powered by 
Analysis
Ultragenyx Pharmaceutical (RARE) Payables (2013 - 2026) Analysis & Trends
At the end of FY2025, Ultragenyx Pharmaceutical posted Payables of $31 million, down 20.5% from FY2024.
- Payables has declined for three consecutive years, though with a five-year compound annual growth rate of 19.1% (FY2020 to FY2025).
- By year, Payables came in at $39 million in FY2024 (-7.4%), $42.11 million in FY2023 (-2.7%), $43.27 million in FY2022 (+152.5%) and $17.14 million in FY2021 (+32.6%).
- Five-year quarterly Payables spans a low of $15.58 million in Q3 2021 and a high of $59.81 million in Q2 2024.
- Year over year, Payables gained in four of the last eight quarters, with an average decline of 4.0%.
- The high point for year-over-year Payables in five years was Q4 2022 (growth of 152.5%); the low point was Q2 2025 (a decline of 42.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $42 million (Q1 2026), $31 million (Q4 2025) and $40.57 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Ultragenyx Pharmaceutical | 1.51 Bn | -292.70 Mn | 180.00 Mn | 39.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 39.00 Mn |
| Mar 31, 2026 | 42.00 Mn |
| Dec 31, 2025 | 31.00 Mn |
| Sep 30, 2025 | 40.57 Mn |
| Jun 30, 2025 | 34.24 Mn |
| Mar 31, 2025 | 47.45 Mn |
| Dec 31, 2024 | 39.00 Mn |
| Sep 30, 2024 | 35.99 Mn |
| Jun 30, 2024 | 59.81 Mn |
| Mar 31, 2024 | 40.97 Mn |
| Dec 31, 2023 | 42.11 Mn |
| Sep 30, 2023 | 33.36 Mn |
| Jun 30, 2023 | 42.12 Mn |
| Mar 31, 2023 | 58.98 Mn |
| Dec 31, 2022 | 43.27 Mn |
| Sep 30, 2022 | 23.53 Mn |
| Jun 30, 2022 | 34.21 Mn |
| Mar 31, 2022 | 23.69 Mn |
| Dec 31, 2021 | 17.14 Mn |
| Sep 30, 2021 | 15.58 Mn |
API Access
Ultragenyx Pharmaceutical Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=RARE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "RARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=RARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();